The global market for Herceptin (Trastuzumab) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body"s own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.

North American market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Herceptin (Trastuzumab) include Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne, Amgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Herceptin (Trastuzumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herceptin (Trastuzumab).

The Herceptin (Trastuzumab) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Herceptin (Trastuzumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Herceptin (Trastuzumab) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Herceptin (Trastuzumab) Market Report

Report Metric	Details
Report Name	Herceptin (Trastuzumab) Market
Segment by Type	Breast Cancer Stomach Cancer Others
Segment by Application	Hospital Medical Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne, Amgen, Samsung Bioepis, Merck, Mylan, Teva Pharmaceutical, Mundipharma, Mabion, AryoGen Biopharma, Genor Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Herceptin (Trastuzumab) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Herceptin (Trastuzumab) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Herceptin (Trastuzumab) Market report?

Ans: The main players in the Herceptin (Trastuzumab) Market are Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited, Bio-Techne, Amgen, Samsung Bioepis, Merck, Mylan, Teva Pharmaceutical, Mundipharma, Mabion, AryoGen Biopharma, Genor Biopharma

What are the Application segmentation covered in the Herceptin (Trastuzumab) Market report?

Ans: The Applications covered in the Herceptin (Trastuzumab) Market report are Hospital, Medical Center

What are the Type segmentation covered in the Herceptin (Trastuzumab) Market report?

Ans: The Types covered in the Herceptin (Trastuzumab) Market report are Breast Cancer, Stomach Cancer, Others

1 Herceptin (Trastuzumab) Market Overview

1.1 Product Definition

1.2 Herceptin (Trastuzumab) by Type

1.2.1 Global Herceptin (Trastuzumab) Market Value Comparison by Type (2024 VS 2031)

1.2.2 Breast Cancer

1.2.3 Stomach Cancer

1.2.4 Others

1.3 Herceptin (Trastuzumab) by Application

1.3.1 Global Herceptin (Trastuzumab) Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Medical Center

1.4 Global Herceptin (Trastuzumab) Market Size Estimates and Forecasts

1.4.1 Global Herceptin (Trastuzumab) Revenue 2020-2031

1.4.2 Global Herceptin (Trastuzumab) Sales 2020-2031

1.4.3 Global Herceptin (Trastuzumab) Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Herceptin (Trastuzumab) Market Competition by Manufacturers

2.1 Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2020-2025)

2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Herceptin (Trastuzumab) Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Herceptin (Trastuzumab), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Herceptin (Trastuzumab), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Herceptin (Trastuzumab), Product Type & Application

2.7 Global Key Manufacturers of Herceptin (Trastuzumab), Date of Enter into This Industry

2.8 Global Herceptin (Trastuzumab) Market Competitive Situation and Trends

2.8.1 Global Herceptin (Trastuzumab) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Herceptin (Trastuzumab) Players Market Share by Revenue

2.8.3 Global Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Herceptin (Trastuzumab) Market Scenario by Region

3.1 Global Herceptin (Trastuzumab) Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Herceptin (Trastuzumab) Sales by Region: 2020-2031

3.2.1 Global Herceptin (Trastuzumab) Sales by Region: 2020-2025

3.2.2 Global Herceptin (Trastuzumab) Sales by Region: 2026-2031

3.3 Global Herceptin (Trastuzumab) Revenue by Region: 2020-2031

3.3.1 Global Herceptin (Trastuzumab) Revenue by Region: 2020-2025

3.3.2 Global Herceptin (Trastuzumab) Revenue by Region: 2026-2031

3.4 North America Herceptin (Trastuzumab) Market Facts & Figures by Country

3.4.1 North America Herceptin (Trastuzumab) Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Herceptin (Trastuzumab) Sales by Country (2020-2031)

3.4.3 North America Herceptin (Trastuzumab) Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Herceptin (Trastuzumab) Market Facts & Figures by Country

3.5.1 Europe Herceptin (Trastuzumab) Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Herceptin (Trastuzumab) Sales by Country (2020-2031)

3.5.3 Europe Herceptin (Trastuzumab) Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Herceptin (Trastuzumab) Market Facts & Figures by Region

3.6.1 Asia Pacific Herceptin (Trastuzumab) Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Herceptin (Trastuzumab) Sales by Region (2020-2031)

3.6.3 Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Herceptin (Trastuzumab) Market Facts & Figures by Country

3.7.1 Latin America Herceptin (Trastuzumab) Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Herceptin (Trastuzumab) Sales by Country (2020-2031)

3.7.3 Latin America Herceptin (Trastuzumab) Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Herceptin (Trastuzumab) Market Facts & Figures by Country

3.8.1 Middle East and Africa Herceptin (Trastuzumab) Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2020-2031)

3.8.3 Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Herceptin (Trastuzumab) Sales by Type (2020-2031)

4.1.1 Global Herceptin (Trastuzumab) Sales by Type (2020-2025)

4.1.2 Global Herceptin (Trastuzumab) Sales by Type (2026-2031)

4.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Type (2020-2031)

4.2 Global Herceptin (Trastuzumab) Revenue by Type (2020-2031)

4.2.1 Global Herceptin (Trastuzumab) Revenue by Type (2020-2025)

4.2.2 Global Herceptin (Trastuzumab) Revenue by Type (2026-2031)

4.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2020-2031)

4.3 Global Herceptin (Trastuzumab) Price by Type (2020-2031)

5 Segment by Application

5.1 Global Herceptin (Trastuzumab) Sales by Application (2020-2031)

5.1.1 Global Herceptin (Trastuzumab) Sales by Application (2020-2025)

5.1.2 Global Herceptin (Trastuzumab) Sales by Application (2026-2031)

5.1.3 Global Herceptin (Trastuzumab) Sales Market Share by Application (2020-2031)

5.2 Global Herceptin (Trastuzumab) Revenue by Application (2020-2031)

5.2.1 Global Herceptin (Trastuzumab) Revenue by Application (2020-2025)

5.2.2 Global Herceptin (Trastuzumab) Revenue by Application (2026-2031)

5.2.3 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2020-2031)

5.3 Global Herceptin (Trastuzumab) Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche Diagnostics

6.1.1 Roche Diagnostics Company Information

6.1.2 Roche Diagnostics Description and Business Overview

6.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio

6.1.5 Roche Diagnostics Recent Developments/Updates

6.2 Genentech

6.2.1 Genentech Company Information

6.2.2 Genentech Description and Business Overview

6.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Genentech Herceptin (Trastuzumab) Product Portfolio

6.2.5 Genentech Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Company Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis AG Herceptin (Trastuzumab) Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Herceptin (Trastuzumab) Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Abnova Corporation

6.5.1 Abnova Corporation Company Information

6.5.2 Abnova Corporation Description and Business Overview

6.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Abnova Corporation Herceptin (Trastuzumab) Product Portfolio

6.5.5 Abnova Corporation Recent Developments/Updates

6.6 InvivoGen

6.6.1 InvivoGen Company Information

6.6.2 InvivoGen Description and Business Overview

6.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.6.4 InvivoGen Herceptin (Trastuzumab) Product Portfolio

6.6.5 InvivoGen Recent Developments/Updates

6.7 Celltrion

6.7.1 Celltrion Company Information

6.7.2 Celltrion Description and Business Overview

6.7.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Celltrion Herceptin (Trastuzumab) Product Portfolio

6.7.5 Celltrion Recent Developments/Updates

6.8 Biocon Limited

6.8.1 Biocon Limited Company Information

6.8.2 Biocon Limited Description and Business Overview

6.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biocon Limited Herceptin (Trastuzumab) Product Portfolio

6.8.5 Biocon Limited Recent Developments/Updates

6.9 Bio-Techne

6.9.1 Bio-Techne Company Information

6.9.2 Bio-Techne Description and Business Overview

6.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Bio-Techne Herceptin (Trastuzumab) Product Portfolio

6.9.5 Bio-Techne Recent Developments/Updates

6.10 Amgen

6.10.1 Amgen Company Information

6.10.2 Amgen Description and Business Overview

6.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Amgen Herceptin (Trastuzumab) Product Portfolio

6.10.5 Amgen Recent Developments/Updates

6.11 Samsung Bioepis

6.11.1 Samsung Bioepis Company Information

6.11.2 Samsung Bioepis Description and Business Overview

6.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio

6.11.5 Samsung Bioepis Recent Developments/Updates

6.12 Merck

6.12.1 Merck Company Information

6.12.2 Merck Description and Business Overview

6.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Merck Herceptin (Trastuzumab) Product Portfolio

6.12.5 Merck Recent Developments/Updates

6.13 Mylan

6.13.1 Mylan Company Information

6.13.2 Mylan Description and Business Overview

6.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Mylan Herceptin (Trastuzumab) Product Portfolio

6.13.5 Mylan Recent Developments/Updates

6.14 Teva Pharmaceutical

6.14.1 Teva Pharmaceutical Company Information

6.14.2 Teva Pharmaceutical Description and Business Overview

6.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio

6.14.5 Teva Pharmaceutical Recent Developments/Updates

6.15 Mundipharma

6.15.1 Mundipharma Company Information

6.15.2 Mundipharma Description and Business Overview

6.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Mundipharma Herceptin (Trastuzumab) Product Portfolio

6.15.5 Mundipharma Recent Developments/Updates

6.16 Mabion

6.16.1 Mabion Company Information

6.16.2 Mabion Description and Business Overview

6.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Mabion Herceptin (Trastuzumab) Product Portfolio

6.16.5 Mabion Recent Developments/Updates

6.17 AryoGen Biopharma

6.17.1 AryoGen Biopharma Company Information

6.17.2 AryoGen Biopharma Description and Business Overview

6.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.17.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio

6.17.5 AryoGen Biopharma Recent Developments/Updates

6.18 Genor Biopharma

6.18.1 Genor Biopharma Company Information

6.18.2 Genor Biopharma Description and Business Overview

6.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Genor Biopharma Herceptin (Trastuzumab) Product Portfolio

6.18.5 Genor Biopharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Herceptin (Trastuzumab) Industry Chain Analysis

7.2 Herceptin (Trastuzumab) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Herceptin (Trastuzumab) Production Mode & Process Analysis

7.4 Herceptin (Trastuzumab) Sales and Marketing

7.4.1 Herceptin (Trastuzumab) Sales Channels

7.4.2 Herceptin (Trastuzumab) Distributors

7.5 Herceptin (Trastuzumab) Customer Analysis

8 Herceptin (Trastuzumab) Market Dynamics

8.1 Herceptin (Trastuzumab) Industry Trends

8.2 Herceptin (Trastuzumab) Market Drivers

8.3 Herceptin (Trastuzumab) Market Challenges

8.4 Herceptin (Trastuzumab) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Herceptin (Trastuzumab) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Herceptin (Trastuzumab) Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Herceptin (Trastuzumab) Market Competitive Situation by Manufacturers in 2024

Table 4. Global Herceptin (Trastuzumab) Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Herceptin (Trastuzumab) Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Herceptin (Trastuzumab), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Herceptin (Trastuzumab), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Herceptin (Trastuzumab), Product Type & Application

Table 12. Global Key Manufacturers of Herceptin (Trastuzumab), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Herceptin (Trastuzumab) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herceptin (Trastuzumab) as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Herceptin (Trastuzumab) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Herceptin (Trastuzumab) Sales by Region (2020-2025) & (K Units)

Table 18. Global Herceptin (Trastuzumab) Sales Market Share by Region (2020-2025)

Table 19. Global Herceptin (Trastuzumab) Sales by Region (2026-2031) & (K Units)

Table 20. Global Herceptin (Trastuzumab) Sales Market Share by Region (2026-2031)

Table 21. Global Herceptin (Trastuzumab) Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2020-2025)

Table 23. Global Herceptin (Trastuzumab) Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2026-2031)

Table 25. North America Herceptin (Trastuzumab) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Herceptin (Trastuzumab) Sales by Country (2020-2025) & (K Units)

Table 27. North America Herceptin (Trastuzumab) Sales by Country (2026-2031) & (K Units)

Table 28. North America Herceptin (Trastuzumab) Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Herceptin (Trastuzumab) Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Herceptin (Trastuzumab) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Herceptin (Trastuzumab) Sales by Country (2020-2025) & (K Units)

Table 32. Europe Herceptin (Trastuzumab) Sales by Country (2026-2031) & (K Units)

Table 33. Europe Herceptin (Trastuzumab) Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Herceptin (Trastuzumab) Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Herceptin (Trastuzumab) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Herceptin (Trastuzumab) Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Herceptin (Trastuzumab) Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Herceptin (Trastuzumab) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Herceptin (Trastuzumab) Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Herceptin (Trastuzumab) Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Herceptin (Trastuzumab) Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Herceptin (Trastuzumab) Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Herceptin (Trastuzumab) Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Herceptin (Trastuzumab) Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Herceptin (Trastuzumab) Sales (K Units) by Type (2020-2025)

Table 51. Global Herceptin (Trastuzumab) Sales (K Units) by Type (2026-2031)

Table 52. Global Herceptin (Trastuzumab) Sales Market Share by Type (2020-2025)

Table 53. Global Herceptin (Trastuzumab) Sales Market Share by Type (2026-2031)

Table 54. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2020-2025)

Table 57. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2026-2031)

Table 58. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2020-2025)

Table 59. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2026-2031)

Table 60. Global Herceptin (Trastuzumab) Sales (K Units) by Application (2020-2025)

Table 61. Global Herceptin (Trastuzumab) Sales (K Units) by Application (2026-2031)

Table 62. Global Herceptin (Trastuzumab) Sales Market Share by Application (2020-2025)

Table 63. Global Herceptin (Trastuzumab) Sales Market Share by Application (2026-2031)

Table 64. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Herceptin (Trastuzumab) Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2020-2025)

Table 67. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2026-2031)

Table 68. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2020-2025)

Table 69. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2026-2031)

Table 70. Roche Diagnostics Company Information

Table 71. Roche Diagnostics Description and Business Overview

Table 72. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Roche Diagnostics Herceptin (Trastuzumab) Product

Table 74. Roche Diagnostics Recent Developments/Updates

Table 75. Genentech Company Information

Table 76. Genentech Description and Business Overview

Table 77. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Genentech Herceptin (Trastuzumab) Product

Table 79. Genentech Recent Developments/Updates

Table 80. Novartis AG Company Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Novartis AG Herceptin (Trastuzumab) Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Herceptin (Trastuzumab) Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Abnova Corporation Company Information

Table 91. Abnova Corporation Description and Business Overview

Table 92. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Abnova Corporation Herceptin (Trastuzumab) Product

Table 94. Abnova Corporation Recent Developments/Updates

Table 95. InvivoGen Company Information

Table 96. InvivoGen Description and Business Overview

Table 97. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. InvivoGen Herceptin (Trastuzumab) Product

Table 99. InvivoGen Recent Developments/Updates

Table 100. Celltrion Company Information

Table 101. Celltrion Description and Business Overview

Table 102. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Celltrion Herceptin (Trastuzumab) Product

Table 104. Celltrion Recent Developments/Updates

Table 105. Biocon Limited Company Information

Table 106. Biocon Limited Description and Business Overview

Table 107. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Biocon Limited Herceptin (Trastuzumab) Product

Table 109. Biocon Limited Recent Developments/Updates

Table 110. Bio-Techne Company Information

Table 111. Bio-Techne Description and Business Overview

Table 112. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Bio-Techne Herceptin (Trastuzumab) Product

Table 114. Bio-Techne Recent Developments/Updates

Table 115. Amgen Company Information

Table 116. Amgen Description and Business Overview

Table 117. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Amgen Herceptin (Trastuzumab) Product

Table 119. Amgen Recent Developments/Updates

Table 120. Samsung Bioepis Company Information

Table 121. Samsung Bioepis Description and Business Overview

Table 122. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Samsung Bioepis Herceptin (Trastuzumab) Product

Table 124. Samsung Bioepis Recent Developments/Updates

Table 125. Merck Company Information

Table 126. Merck Description and Business Overview

Table 127. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Merck Herceptin (Trastuzumab) Product

Table 129. Merck Recent Developments/Updates

Table 130. Mylan Company Information

Table 131. Mylan Description and Business Overview

Table 132. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Mylan Herceptin (Trastuzumab) Product

Table 134. Mylan Recent Developments/Updates

Table 135. Teva Pharmaceutical Company Information

Table 136. Teva Pharmaceutical Description and Business Overview

Table 137. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Teva Pharmaceutical Herceptin (Trastuzumab) Product

Table 139. Teva Pharmaceutical Recent Developments/Updates

Table 140. Mundipharma Company Information

Table 141. Mundipharma Description and Business Overview

Table 142. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Mundipharma Herceptin (Trastuzumab) Product

Table 144. Mundipharma Recent Developments/Updates

Table 145. Mabion Company Information

Table 146. Mabion Description and Business Overview

Table 147. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Mabion Herceptin (Trastuzumab) Product

Table 149. Mabion Recent Developments/Updates

Table 150. AryoGen Biopharma Company Information

Table 151. AryoGen Biopharma Description and Business Overview

Table 152. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. AryoGen Biopharma Herceptin (Trastuzumab) Product

Table 154. AryoGen Biopharma Recent Developments/Updates

Table 155. Genor Biopharma Company Information

Table 156. Genor Biopharma Description and Business Overview

Table 157. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. Genor Biopharma Herceptin (Trastuzumab) Product

Table 159. Genor Biopharma Recent Developments/Updates

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Herceptin (Trastuzumab) Distributors List

Table 163. Herceptin (Trastuzumab) Customers List

Table 164. Herceptin (Trastuzumab) Market Trends

Table 165. Herceptin (Trastuzumab) Market Drivers

Table 166. Herceptin (Trastuzumab) Market Challenges

Table 167. Herceptin (Trastuzumab) Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

Table 171. Authors List of This Report

List of Figures

Figure 1. Product Picture of Herceptin (Trastuzumab)

Figure 2. Global Herceptin (Trastuzumab) Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Herceptin (Trastuzumab) Market Share by Type: 2024 & 2031

Figure 4. Breast Cancer Product Picture

Figure 5. Stomach Cancer Product Picture

Figure 6. Others Product Picture

Figure 7. Global Herceptin (Trastuzumab) Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Herceptin (Trastuzumab) Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Medical Center

Figure 11. Global Herceptin (Trastuzumab) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Herceptin (Trastuzumab) Market Size (2020-2031) & (US$ Million)

Figure 13. Global Herceptin (Trastuzumab) Sales (2020-2031) & (K Units)

Figure 14. Global Herceptin (Trastuzumab) Average Price (USD/Unit) & (2020-2031)

Figure 15. Herceptin (Trastuzumab) Report Years Considered

Figure 16. Herceptin (Trastuzumab) Sales Share by Manufacturers in 2024

Figure 17. Global Herceptin (Trastuzumab) Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Herceptin (Trastuzumab) Players: Market Share by Revenue in Herceptin (Trastuzumab) in 2024

Figure 19. Herceptin (Trastuzumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Herceptin (Trastuzumab) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Herceptin (Trastuzumab) Sales Market Share by Country (2020-2031)

Figure 22. North America Herceptin (Trastuzumab) Revenue Market Share by Country (2020-2031)

Figure 23. United States Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2020-2031)

Figure 26. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2020-2031)

Figure 27. Germany Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Herceptin (Trastuzumab) Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Herceptin (Trastuzumab) Revenue Market Share by Region (2020-2031)

Figure 34. China Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Herceptin (Trastuzumab) Sales Market Share by Country (2020-2031)

Figure 44. Latin America Herceptin (Trastuzumab) Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Herceptin (Trastuzumab) Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Herceptin (Trastuzumab) Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Herceptin (Trastuzumab) by Type (2020-2031)

Figure 54. Global Revenue Market Share of Herceptin (Trastuzumab) by Type (2020-2031)

Figure 55. Global Herceptin (Trastuzumab) Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Herceptin (Trastuzumab) by Application (2020-2031)

Figure 57. Global Revenue Market Share of Herceptin (Trastuzumab) by Application (2020-2031)

Figure 58. Global Herceptin (Trastuzumab) Price (USD/Unit) by Application (2020-2031)

Figure 59. Herceptin (Trastuzumab) Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HER2 Antibody Market Research Report 2025

Herceptin Trastuzumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herceptin Biosimilar Market Insights Forecast to 2030

Trastuzumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mono Antibody mAb for HER2 Positive Advanced Breast Cancer Market Research Report 2024

Global Anti HER2 Therapy Market Research Report 2025

Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024

Global Trastuzumab Market Research Report 2025

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global HER2 Antibody Drug Conjugate Market Research Report 2025

Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024

Global HER2 Positive Breast Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Market Research Report 2024

Global HER 2 Targeted Drugs for Breast Cancer Market Research Report 2024

Global Matuzumab Market Research Report 2024

Global Pertuzumab Market Research Report 2025

Global Targeted Drug HER2 Inhibitors for NSCLC Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions